Bigfoot acquires Asante assets, inks deal with Dexcom

Bigfoot Biomedical is making strides towards its goal of a bionic pancreas after inking a deal with Dexcom Inc. (NSDQ:DXCM), maker of continuous glucose monitors, and acquiring the assets of shuttered insulin pump maker Asante. Bigfoot also said it will be relocating to Milpitas, Calif., where Asante was headquartered. The deal signed with Dexcom is slated to allow Bigfoot to integrate data from Dexcom’s continuous glucose monitoring systems into its insulin delivery system, it said last week. The deal makes sense, as the “homebrew artificial pancreas” system created by Bigfoot co-founder Bryan Mazlish that made headlines last year operated on a Dexcom CGM, his wife, Dr. Sarah Kimball, said in an interview with Healthline. “We are thrilled to be working with such an innovative, impactful and highly-respected partner. Bigfoot Biomedical exists to serve the needs of the Type I diabetes community, and this partnership is our most important collaboration toward delivering an automated insulin delivery solution for people with T1D,” Bigfoot CEO Jeffrey Brewer said in prepared remarks. “Dexcom’s advanced technologies are a great fit for Bigfoot’s pioneering efforts towards an artificial pancreas. Bigfoot has made a commitment to automated insulin control based on CGM data, and Dexcom is excited to participate in their development efforts with our sensor technology,” Dexcom executive vp of strategy & corporate develop...
Source: Mass Device - Category: Medical Equipment Authors: Tags: Business/Financial News Diabetes Mergers & Acquisitions mHealth (Mobile Health) Asante Solutions Bigfoot Biomedical DexCom Inc. newtag Source Type: news